Decontamination of Creutzfeldt-Jakob Disease and other transmissible agents

Journal of NeuroVirology

Volumn 3, Issue 1, 1997, Pages 62-65

  Manuelidis, Laura ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bovine spongiform encephalopathy; Hepatitis B; Prion; Scrapie

Indexed keywords

GUANIDINE DERIVATIVE; GUANIDINE THIOCYANATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BOVINE SPONGIFORM ENCEPHALOPATHY; BRAIN; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; INSTRUMENT STERILIZATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; BOVINAE;

EID: 0031059831     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289709015793     Document Type: Article

References (20)

1. Anderson RM, Donnelly CA, Ferguson NM, Woolhouse MEJ, Watt CJ, Udy HJ, MaWhinney S, Dunstan SP, Southwood TRE, Wilesmith JW (1996). Transmission dynamics and epidemiology of BSE in British cattle. Nature 382: 779-788.
2. Bessen RA, Kocisko DA, Raymond GH, Nandan S, Lansbury PT, Caughey B (1995). Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 375: 698-700.
3. Bruce ME, Dickinson AG (1987). Biological evidence that scrapie has an independent genome. J Gen Virol 68: 79-89.
4. Bruce ME (1993). Scrapie strain variation and mutation. Br Med Bull 49: 822-838.
5. Diringer H, Blode H, Oberdieck U (1991). Virus-induced amyloidosis in scrapie involves a change in covalent linkage in the preamyloid. Arch Virol 118: 127-131.
6. Dron M, Manuelidis L (1996). Visualization of viral candidate cDNAs in infectious brain fractions from Creutzfeldt-Jakob Disease by representational difference analysis. J Neurovirol 2: 240-248.
7. Lasemezas C, Deslys J-P, Demaimay R, Adjou K, Lamoury F, Dormont D, Robain O, Ironside J, Hauw J-J (1996). BSE transmission to macaques. Nature 381: 733-734.
8. Lewis DL, Arens M (1995). Resistance of microorganisms to disinfection in dental and medical devices. Nature Medicine 1: 956-958.
9. Manuelidis EE, Gorgacz EJ, Manuelidis L (1978). Viremia in experimental Creutzfeldt-Jakob disease. Science 200: 1069-1071.
10. Manuelidis L, Sklaviadis T, Manuelidis EE (1987). Evidence suggesting that PrP is not the infectious agent in Creutzfeldt-Jakob disease. EMBO J 6: 341-347.
11. Manuelidis L (1994). The dimensions of Creutzfeldt-Jakob Disease. Transfusion 34: 915-928.
12. Manuelidis L, Sklaviadis T, Akowitz A, Fritch W (1995). Viral particles are required for infection in neurodegenerative Creutzfeld-Jakob Disease. Proc Natl Acad Sci USA 92: 5124-5128.
13. Manuelidis L, Fritch W (1996). Infectivity and host responses in Creutzfeldt-Jakob Disease. Virology 215: 46-59.
14. McKinnon DJ (1996). Thirty new cases of Hepatitis B found. All had EEGs at six clinics, officials say. Toronto Star page SC4.
15. Oken R, McGeer P (1995). Letter to the editor. J Dental Res 74: 1836.
16. Prusiner SB (1991). Molecular biology of prion diseases. Science 252: 1515-1522.
17. Riesner D, Kellings K, Wiese U, Wulfert M, Mirenda C, Prusiner SB (1996). Disruption of prion rods generates 10-nm spherical particles having high a-helical content and lacking scrapie infectivity. J Virol 70: 1714-1722.
18. Rizza CR, Fletcher ML, Kernoff PB (1983). Confirmation of viral safety of dry heated factor VIII concentrate (8Y) prepared by Bio Products Laboratory (BPL): a report on behalf of UK Haemophilia Centre Directors. Br J Haematol 84: 269-272.
19. Will R, Ironside J, Zeidler M, Cousens S, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith P (1996). A new variant of Creutzfeldt-Jakob Disease in the UK. Lancet 347: 921-925.
20. Xi YG, Ingrosso A, Ladogana A, Masullo C, Pocchiari M (1992). Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation. Nature 356: 598-601.